| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/26/2009 | US20090053234 Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents |
| 02/26/2009 | US20090053232 Modulation of synaptogenesis |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053210 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 02/26/2009 | US20090053203 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, obesity, cardiovascular, metabolic, neurodegenerative, gastrointestinal, autoimmune, rheumatological and infectious diseases; drug delivery |
| 02/26/2009 | CA2734577A1 Inflammation-regulating compositions and methods |
| 02/25/2009 | EP2028493A1 Procalcitonin 3-116 |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027854A1 Analgesic uses of norketamine and ketamine/norketamine prodrugs |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2027105A2 Novel process for preparing intermediates of ccr antagonists |
| 02/25/2009 | EP2027092A1 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 02/25/2009 | EP2026806A2 Use of vx-702 for treating rheumatoid arthritis |
| 02/25/2009 | EP2026804A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
| 02/25/2009 | EP1856031B1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 02/25/2009 | EP1572246B1 Novel compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 02/25/2009 | EP1392270B1 Abuse resistant pharmaceutical composition containing capsaicin |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | EP1075277B1 Methods for detecting and inhibiting angiogenesis |
| 02/25/2009 | CN101374849A Quinoline-4-ketones derivates as ABC transport protein regulation/control agent |
| 02/25/2009 | CN101374844A Pyrrolopyridazinone compound |
| 02/25/2009 | CN101374839A Azaindoles useful as inhibitors of janus kinases |
| 02/25/2009 | CN101374830A Alpha2C adrenoreceptor agonists |
| 02/25/2009 | CN101374826A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 02/25/2009 | CN101374531A Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
| 02/25/2009 | CN101372514A Scaphium scaphigerum polysaccharide, preparation and use thereof |
| 02/25/2009 | CN101372499A Novel medicament having antiinflammatory activity |
| 02/25/2009 | CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/25/2009 | CN101371923A BAFF receptor (BCMA), an immunoregulatory agent |
| 02/25/2009 | CN101371912A Chinese medicine oral decoction for treating dysmenorrhea |
| 02/25/2009 | CN101371879A Aconitum sinomontanum transdermal paster and preparation method thereof |
| 02/25/2009 | CN101371878A External-use Chinese medicinal composition for treating painful swelling disease |
| 02/25/2009 | CN101371832A Medical use of triacetyl andrographolide as proinflammatory cytokine inhibitor |
| 02/25/2009 | CN101371823A Technique for preparing double-acetyl emodic acid sustained-release capsules |
| 02/25/2009 | CN101371710A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 02/25/2009 | CN100463689C Method for preparing gel for wean to remove heat |
| 02/25/2009 | CN100463670C Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495081 Framework patched anti-CD20 antibody |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 02/24/2009 | US7495004 Purine derivatives as liver X receptor agonists |
| 02/24/2009 | US7494976 Antiinflammatory agents; anticancer agents; cholesterol binding protein |
| 02/24/2009 | US7494973 Therapeutic fibrin-derived peptides and uses thereof |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | US7494652 polyclonal antibodies comprising tumor necrosis factor, b-cell differentiation factor and interferon antibodies, directed to cytokines, used for treatment of septic shock in animals, including humans |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/24/2009 | CA2444208C Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2362888C Use of r-aryl propionic acids for producing medicaments to treat diseases in humans and animals, whereby said diseases can be therapeutically influenced by inhibiting the activation of nf-kb |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2262582C Hcg and derivatives as matrix metalloproteases inhibitors |
| 02/19/2009 | WO2009023752A1 Adrenergic compounds |
| 02/19/2009 | WO2009023653A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | WO2009023471A2 Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation |
| 02/19/2009 | WO2009023030A1 Immediate release and sustained release ibuprofen dosing regimen |
| 02/19/2009 | WO2009022731A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2009022730A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009022346A2 Phenyl carbamates for treating gastrointestinal inflammation |
| 02/19/2009 | WO2009022345A1 Phenyl carbamates for the treatment of multiple sclerosis |
| 02/19/2009 | WO2008155520A3 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 02/19/2009 | WO2008152423A3 Treatment of inflammation or autoimmune diseases with sulphated compounds |
| 02/19/2009 | WO2008148932A3 Glycosylasparaginase for treatment of cancers or inflammatory diseases |
| 02/19/2009 | WO2008142517A3 Synthetic peptide having anti-inflammatory and anti-microbic properties |
| 02/19/2009 | WO2008109856A3 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
| 02/19/2009 | WO2008109352A4 Nucleic acid compounds for inhibiting akt gene expression and uses thereof |
| 02/19/2009 | WO2008063842A3 Methods of treating neuropathic pain with agonists of ppar-gamma |
| 02/19/2009 | WO2008060766A3 Histamine h4 receptor ligands for use in pain treatment |
| 02/19/2009 | WO2008057246A3 Method for treating inflammatory disorders |
| 02/19/2009 | WO2008018827A8 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/19/2009 | WO2006065484A3 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048435 Oligonucleotide modulation of cell adhesion |
| 02/19/2009 | US20090048343 Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field |
| 02/19/2009 | US20090048330 Compound from Antrodia camphorata and the use thereof |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048300 Heterocyclic Compounds |
| 02/19/2009 | US20090048291 Novel Piperidine-4-Acetic Acid Derivatives and Their Use |
| 02/19/2009 | US20090048290 2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzyofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/19/2009 | US20090048281 Organic Compounds |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048245 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048235 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | US20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048221 Conjugates with Anti-Inflammatory Activity |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/19/2009 | US20090048167 Disease treatment via antimicrobial peptides or their inhibitors |
| 02/19/2009 | US20090048149 Antagonists of the bradykinin B1 receptor |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047324 Medical Devices Containing Rapamycin Analogs |
| 02/19/2009 | US20090047234 Compositions for nasal delivery |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |